Diabetes and Endocrine — All Questions

When performing a urinalysis, which of the following does not need to be tested for?

Under 49 CFR 391.46, what must an individual with insulin-treated diabetes mellitus provide to the treating clinician for each evaluation?

Under 49 CFR 391.46(e), which of the following defines a severe hypoglycemic episode for an ITDM driver?

What is the certification outcome for a driver with insulin-treated diabetes who has experienced a severe hypoglycemic episode?

) If glucose is detected on urinalysis in a driver with no history of diabetes, an appropriate next step is:

Tests not required as part of every driver certification and recertification examination include:

How often must a driver certified under 49 CFR 391.46 for ITDM be recertified?

What form must the treating clinician complete for an ITDM driver under 49 CFR 391.46 before each medical examination?

A driver checks blood glucose before driving and finds it is 55 mg/dL. What should they do?

What blood glucose level is considered the lower threshold of concern before driving a CMV?

A driver’s blood glucose log shows multiple readings above 300 mg/dL in the past month. What does this indicate?

What symptoms of hypoglycemia should a CMV driver be educated about?

Hypoglycemia unawareness in a diabetic CMV driver is considered what?

What constitutes a severe hypoglycemic episode per FMCSA guidelines?

What is the primary purpose of the A1c test in evaluating diabetic CMV drivers?

An A1c of 6.5% in a CMV driver indicates what?

A driver with type 2 diabetes controlled on metformin alone has an A1c of 7.2%. What certification is appropriate?

A driver with type 2 diabetes recently started insulin injections in addition to oral medications. What changes for certification?

A driver with type 1 diabetes on an insulin pump applies for CMV certification. What is required?

A non-insulin-treated diabetic driver presents with an A1c of 11.5%. What should the examiner do?

A 58-year-old driver presents for DOT exam with fasting glucose of 280 mg/dL and an A1c of 10.8%. The driver was not previously known to have diabetes. What is the appropriate action?

A driver with well-controlled type 2 diabetes on metformin presents with a pre-exam glucose of 145 mg/dL. What certification is appropriate?

A driver with type 2 diabetes on oral medications has progressive numbness in both feet. What should the examiner evaluate?

A driver certified under 49 CFR 391.46 for ITDM reports blood glucose of 42 mg/dL while driving last week but treated it themselves without needing help. Is this a disqualifying event?

What specific features must the blood glucose monitoring device meet under 49 CFR 391.46(d)?

What is the primary benefit of a continuous glucose monitor (CGM) for a diabetic CMV driver?

A driver with type 2 diabetes not on insulin presents with a 3-day glucose log showing all readings between 90-180 mg/dL. What does this suggest?

A driver with type 2 diabetes on oral medications develops blurred vision. What should the examiner consider?

Diabetic retinopathy can affect a CMV driver’s certification by impacting what standard?

A driver with diabetic autonomic neuropathy affecting blood pressure regulation should be evaluated for what?

What must a medical examiner specifically document when certifying a non-insulin diabetic driver?

An ITDM-certified driver lost their blood glucose monitoring equipment and has not checked glucose for 3 days. What should happen?

A driver with gestational diabetes is being evaluated for CMV certification postpartum. What is the appropriate approach?

A driver with pre-diabetes (A1c 5.7-6.4%) should receive what determination?

A CMV driver with type 2 diabetes on a GLP-1 receptor agonist (semaglutide) should receive what consideration?

A driver with type 1 diabetes asks if they can operate a CMV without ITDM certification under 49 CFR 391.46 if they only drive intrastate. What is correct?

A driver taking metformin and glipizide has a pre-exam glucose of 68 mg/dL and reports feeling slightly shaky. What should the examiner do?

What is the significance of diabetic gastroparesis for CMV driver certification?

A driver with well-controlled type 2 diabetes on oral medication develops a foot ulcer. What should the examiner evaluate?

What substances does the DOT urinalysis specifically test for?

Why is protein detected on a DOT urinalysis clinically significant?

Glucose detected on DOT urinalysis should prompt the medical examiner to evaluate for which condition?

A DOT urinalysis shows 3+ blood. What is the most appropriate next step?

How often is a urinalysis performed as part of the DOT physical examination?

A driver’s DOT urinalysis shows 1+ protein and trace blood. The driver has no history of kidney disease. What should the examiner do?

Can a DOT urinalysis show positive for glucose in a non-diabetic driver?

What does specific gravity on a urinalysis indicate?

A driver on DOT urinalysis has 2+ sugar. The driver was not previously known to be diabetic. What is the examiner’s appropriate action?

The DOT urinalysis does NOT test for which of the following?

A driver with chronic kidney disease stage 3 (GFR 30-59 mL/min) who is stable should receive what certification determination?

At what stage of chronic kidney disease does dialysis typically become necessary?

A driver with CKD stage 4 (GFR 15-29) who is not yet on dialysis should receive what determination?

Which complication of advanced CKD is most concerning for safe CMV operation?

What CKD-related laboratory abnormality should the examiner screen for that could affect driving safety?

A driver with CKD stage 2 (GFR 60-89) who has no symptoms and controlled blood pressure should receive what determination?

Can a driver who is on hemodialysis be certified to operate a CMV?

What is the primary concern with certifying a CMV driver who undergoes hemodialysis?

A driver on peritoneal dialysis who performs exchanges at home should be evaluated for what before certification?

A DOT urinalysis reveals 2+ protein in a driver with known diabetes. What should the examiner evaluate?

Microscopic hematuria found on DOT urinalysis in an otherwise healthy driver warrants what evaluation?

What is the significance of heavy proteinuria (3+ or 4+) on DOT urinalysis?

A driver with isolated trace protein on DOT urinalysis who had vigorous exercise that morning should receive what recommendation?

A driver presents with bilateral flank pain and urinalysis showing blood and protein. The driver also has a creatinine of 3.5 mg/dL. What determination is most appropriate?

What renal condition is most likely to be identified initially through the DOT urinalysis?

A driver using insulin to treat type 2 diabetes needs which of the following to operate a CMV in interstate commerce?

A urinalysis showing 2+ protein in a CMV driver should prompt the examiner to do what?

Which stage of diabetic retinopathy would most likely disqualify a CMV driver from medical certification under FMCSA standards?

A CMV driver with diabetes reports recent laser photocoagulation treatment for diabetic retinopathy. What should the medical examiner require before recertification?

How does diabetic peripheral neuropathy affect a CMV driver’s ability to safely operate a commercial vehicle?

During the physical examination, which clinical test is most important for assessing diabetic peripheral neuropathy in a CMV driver’s lower extremities?

A CMV driver with longstanding diabetes presents with gastroparesis. Why is this condition a concern for driving safety?

What is the significance of diabetic autonomic neuropathy affecting the cardiovascular system in a CMV driver?

A diabetic CMV driver has been diagnosed with stage 3 chronic kidney disease (eGFR 45 mL/min) due to diabetic nephropathy. How should the medical examiner approach certification?

Which diabetic complication involving the foot would most directly impair a CMV driver’s ability to operate vehicle pedals safely?

A CMV driver with diabetes has had anti-VEGF injections for diabetic macular edema. What must the medical examiner verify?

What must happen before an ITDM driver who experienced a severe hypoglycemic episode can resume operating a CMV?

What is ‘hypoglycemia unawareness’ and why is it particularly dangerous for CMV drivers?

A CMV driver with insulin-treated diabetes reports a severe hypoglycemic episode requiring third-party assistance 3 months ago. How does this affect ITDM certification?

Which of the following neuroglycopenic symptoms of hypoglycemia poses the greatest immediate danger to a CMV driver?

A CMV driver’s ITDM monitoring log shows blood glucose values consistently between 60-70 mg/dL before meals. What should the medical examiner conclude?

Under current FMCSA regulations, what is the key difference in certification pathway between a Type 1 and Type 2 CMV driver who both require insulin?

How does the certification interval typically differ for a well-controlled Type 2 diabetic driver on oral medications versus an insulin-requiring driver under the 49 CFR 391.46 ITDM?

A Type 2 diabetic CMV driver whose physician is adding insulin to their oral medication regimen asks about driving implications. What must the medical examiner explain?

What happens to a Type 1 diabetic CMV driver’s certification if they experience a diabetes-related seizure while off duty?

How does the medical examiner differentiate between a Type 2 diabetic driver who requires insulin for treatment versus one using insulin only for short-term management (e.g., perioperative use)?

A CMV driver with Type 1 diabetes has a history of two DKA episodes in the past year. How should the medical examiner evaluate this history?

Under 49 CFR 391.46, what form must the treating clinician complete for a driver with insulin-treated diabetes mellitus?

What is the maximum certification period for a CMV driver with insulin-treated diabetes mellitus certified under 49 CFR 391.46?

A driver with insulin-treated diabetes mellitus has been diagnosed with proliferative diabetic retinopathy. What is the certification determination?

How many months of electronic blood glucose self-monitoring records must an ITDM driver provide to the treating clinician before certification?

Who is defined as the ‘treating clinician’ under 49 CFR 391.46 for ITDM drivers?

An individual with insulin-treated diabetes mellitus is not maintaining a stable insulin regimen and is not properly controlling the diabetes. What should the ME determine?

Which type of diabetic retinopathy does NOT permanently disqualify an ITDM driver from certification under 391.46?

Why does treatment for advanced diabetic retinopathy preclude CMV certification for ITDM drivers?

What is the maximum certification period for a driver with non-insulin-treated diabetes mellitus that is well controlled?

A driver with non-insulin-treated diabetes mellitus reports frequent hypoglycemic episodes resulting in loss of consciousness. Under which standard should the ME consider this condition?

Under which physical qualification standard would an ME evaluate peripheral neuropathy caused by non-insulin-treated diabetes?

Which symptoms should the ME inquire about when evaluating a driver with non-insulin-treated diabetes?

Hypertension associated with diabetes mellitus should be evaluated under which physical qualification standard?

Under which physical qualification standard would diabetic retinopathy in a non-insulin-treated driver be evaluated?

What laboratory values may the ME consult when evaluating a driver with diabetes and abnormal urine findings?

Protein, blood, or sugar in the urine may indicate which underlying medical conditions that require further testing?

The MCSA-5870 form asks the treating clinician to attest to which two key findings about the ITDM driver?

Cardiac complications and nephropathy with cardiac complications in a non-insulin-treated diabetic driver should be evaluated under which standard?

What numerical readings must the ME record from the urinalysis during the physical qualification examination?

When does renal dialysis become necessary according to the handbook?

What symptoms may an individual experience pre- or post-dialysis that the ME should consider when evaluating CMV fitness?

End stage renal disease resulting from cardiovascular conditions such as hypertension or congestive heart failure should be considered under which standard?

End stage renal disease resulting from insulin-treated diabetes mellitus should be considered under which physical qualification standard?

Peritoneal dialysis differs from hemodialysis in that it uses which anatomical structure to filter the blood?

A driver with ITDM presents with documentation from the treating clinician. The MCSA-5870 indicates severe non-proliferative diabetic retinopathy. Can the ME exercise independent judgment rather than relying solely on the form?

A non-insulin-treated diabetic driver has developed an amputation of one foot. Under which physical qualification standards should this complication be evaluated?

What is the key distinction between the regulatory requirements for insulin-treated and non-insulin-treated diabetes mellitus?

An ITDM driver’s treating clinician must sign a new MCSA-5870 form at what interval?

If sugar is found in the urine during the DOT physical, what should the ME do?

The disqualification for severe diabetic retinopathy under 391.46(c)(2)(ii) applies to which group of drivers?

A driver with non-insulin-treated diabetes reports compliance with treatment, no hypoglycemic episodes, and well-controlled blood sugar. The ME should also assess what?

An individual with non-insulin-treated diabetes has developed nephropathy with cardiac complications. Which standards should the ME consider?

The Insulin-Treated Diabetes Mellitus Assessment Form (MCSA-5870) must be completed and signed by which healthcare professional?

A driver with non-insulin-treated diabetes mellitus reports symptoms including frequent urination, excessive thirst, and numbness in the hands and feet. What should the ME consider?

A driver with insulin-treated diabetes mellitus has been providing glucose monitoring records for only 2 months instead of the required 3 months. What is the maximum certification period the ME may issue?

An ITDM driver experiences a severe hypoglycemic episode while driving. What must happen before the driver can resume operating a CMV?